Literature DB >> 27165961

Hospitalized Infection as a Trigger for Acute Ischemic Stroke: The Atherosclerosis Risk in Communities Study.

Logan T Cowan1, Alvaro Alonso2, James S Pankow2, Aaron R Folsom2, Wayne D Rosamond2, Rebecca F Gottesman2, Kamakshi Lakshminarayan2.   

Abstract

BACKGROUND AND
PURPOSE: Acute triggers for ischemic stroke, which may include infection, are understudied, as is whether background cardiovascular disease (CVD) risk modifies such triggering. We hypothesized that infection increases acute stroke risk, especially among those with low CVD risk.
METHODS: Hospitalized strokes and infections were identified in the Atherosclerosis Risk in Communities (ARIC) cohort. A case-crossover design and conditional logistic regression were used to compare hospitalized infections among patients with stroke (14, 30, 42, and 90 days before stroke) with corresponding control periods 1 year and 2 years before stroke. Background CVD risk was assessed at both visit 1 and the visit most proximal to stroke, with risk dichotomized at the median.
RESULTS: A total of 1008 adjudicated incident ischemic strokes were included. Compared with control periods, hospitalized infection was more common within 2 weeks before stroke (14-day odds ratio [OR], 7.7; 95% CI, 2.1-27.3); the strength of association declined with increasing time in the exposure window before stroke (30-day OR, 5.7 [95% CI, 2.3-14.3]; 42-day OR, 4.5 [95% CI, 2.0-10.2]; and 90-day OR, 3.6 [95% CI, 2.1-6.5]). Stroke risk was higher among those with low compared with high CVD risk, with this interaction reaching statistical significance for some exposure periods.
CONCLUSIONS: These results support the hypothesis that hospitalized infection is a trigger of ischemic stroke and may explain some cryptogenic strokes. Infection control efforts may prevent strokes. CVD preventive therapies may prevent strokes if used in the peri-infection period, but clinical trials are needed.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  hospitalization; infection; risk factors; stroke

Mesh:

Year:  2016        PMID: 27165961      PMCID: PMC4879064          DOI: 10.1161/STROKEAHA.116.012890

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  21 in total

1.  Randomized secondary prevention trial of azithromycin in patients with coronary artery disease: primary clinical results of the ACADEMIC study.

Authors:  J B Muhlestein; J L Anderson; J F Carlquist; K Salunkhe; B D Horne; R R Pearson; T J Bunch; A Allen; S Trehan; C Nielson
Journal:  Circulation       Date:  2000-10-10       Impact factor: 29.690

2.  2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  David C Goff; Donald M Lloyd-Jones; Glen Bennett; Sean Coady; Ralph B D'Agostino; Raymond Gibbons; Philip Greenland; Daniel T Lackland; Daniel Levy; Christopher J O'Donnell; Jennifer G Robinson; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Paul Sorlie; Neil J Stone; Peter W F Wilson; Harmon S Jordan; Lev Nevo; Janusz Wnek; Jeffrey L Anderson; Jonathan L Halperin; Nancy M Albert; Biykem Bozkurt; Ralph G Brindis; Lesley H Curtis; David DeMets; Judith S Hochman; Richard J Kovacs; E Magnus Ohman; Susan J Pressler; Frank W Sellke; Win-Kuang Shen; Sidney C Smith; Gordon F Tomaselli
Journal:  Circulation       Date:  2013-11-12       Impact factor: 29.690

Review 3.  Role of acute infection in triggering acute coronary syndromes.

Authors:  Vicente F Corrales-Medina; Mohammad Madjid; Daniel M Musher
Journal:  Lancet Infect Dis       Date:  2010-02       Impact factor: 25.071

4.  Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis.

Authors:  Jacob A Udell; Rami Zawi; Deepak L Bhatt; Maryam Keshtkar-Jahromi; Fiona Gaughran; Arintaya Phrommintikul; Andrzej Ciszewski; Hossein Vakili; Elaine B Hoffman; Michael E Farkouh; Christopher P Cannon
Journal:  JAMA       Date:  2013-10-23       Impact factor: 56.272

5.  Hypertensive crisis: clinical-epidemiological profile.

Authors:  José Fernando Vilela-Martin; Renan Oliveira Vaz-de-Melo; Cristina Hiromi Kuniyoshi; André Neder Ramires Abdo; Juan Carlos Yugar-Toledo
Journal:  Hypertens Res       Date:  2010-12-16       Impact factor: 3.872

6.  Hospitalization for infection and risk of acute ischemic stroke: the Cardiovascular Health Study.

Authors:  Mitchell S V Elkind; Cara L Carty; Ellen S O'Meara; Thomas Lumley; David Lefkowitz; Richard A Kronmal; W T Longstreth
Journal:  Stroke       Date:  2011-05-05       Impact factor: 7.914

7.  Preceding infection as an important risk factor for ischaemic brain infarction in young and middle aged patients.

Authors:  J Syrjänen; V V Valtonen; M Iivanainen; M Kaste; J K Huttunen
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-23

8.  Acute infection contributes to racial disparities in stroke mortality.

Authors:  Deborah A Levine; Kenneth M Langa; Mary A M Rogers
Journal:  Neurology       Date:  2014-02-07       Impact factor: 9.910

9.  Association of symptoms of chronic bronchitis and frequent flu-like illnesses with stroke.

Authors:  Armin J Grau; Michael R Preusch; Frederik Palm; Christoph Lichy; Heiko Becher; Florian Buggle
Journal:  Stroke       Date:  2009-08-13       Impact factor: 7.914

10.  The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators.

Authors: 
Journal:  Am J Epidemiol       Date:  1989-04       Impact factor: 4.897

View more
  14 in total

1.  Infection During Delivery Hospitalization and Risk of Readmission for Postpartum Stroke.

Authors:  Eliza C Miller; Timothy Wen; Mitchell S V Elkind; Alexander M Friedman; Amelia K Boehme
Journal:  Stroke       Date:  2019-08-15       Impact factor: 7.914

2.  Hospitalization with infection and incident venous thromboembolism: The ARIC study.

Authors:  Logan T Cowan; Pamela L Lutsey; James S Pankow; Mary Cushman; Aaron R Folsom
Journal:  Thromb Res       Date:  2017-01-25       Impact factor: 3.944

Review 3.  Infection as a Stroke Risk Factor and Determinant of Outcome After Stroke.

Authors:  Mitchell S V Elkind; Amelia K Boehme; Craig J Smith; Andreas Meisel; Marion S Buckwalter
Journal:  Stroke       Date:  2020-09-08       Impact factor: 7.914

4.  Challenges of stroke management in resource-limited settings: A case-based reflection.

Authors:  Yohane G Gadama; Gloria Mwangalika; Louis B Kinley; Beth Jackson; Henry C Mwandumba; Jane Mallewa; Tom Solomon; Rob Simister; Laura A Benjamin; Maria I Vargas; Joseph Kamtchum-Tatuene; Tamara Phiri
Journal:  Malawi Med J       Date:  2017-06       Impact factor: 0.875

5.  Influenza-like illness as a trigger for ischemic stroke.

Authors:  Amelia K Boehme; Jorge Luna; Erin R Kulick; Hooman Kamel; Mitchell S V Elkind
Journal:  Ann Clin Transl Neurol       Date:  2018-03-14       Impact factor: 4.511

6.  Spark That Lights the Fire: Infection Triggers Cardiovascular Events.

Authors:  Carlos G Santos-Gallego; Álvaro García-Ropero; Juan J Badimon
Journal:  J Am Heart Assoc       Date:  2018-11-20       Impact factor: 5.501

7.  Inpatient and Outpatient Infection as a Trigger of Cardiovascular Disease: The ARIC Study.

Authors:  Logan T Cowan; Pamela L Lutsey; James S Pankow; Kunihiro Matsushita; Junichi Ishigami; Kamakshi Lakshminarayan
Journal:  J Am Heart Assoc       Date:  2018-11-20       Impact factor: 5.501

8.  Predictors of urinary tract infection in acute stroke patients: A cohort study.

Authors:  Ya-Ming Li; Jian-Hua Xu; Yan-Xin Zhao
Journal:  Medicine (Baltimore)       Date:  2020-07-02       Impact factor: 1.817

9.  Serum concentration of anti-Cytomegalovirus IgG and ischaemic stroke in patients with advanced HIV infection in Malawi.

Authors:  Joseph Kamtchum-Tatuene; Zaid Al-Bayati; Henry Charles Mwandumba; Tom Solomon; Stephen E Christmas; Laura A Benjamin
Journal:  PLoS One       Date:  2018-11-27       Impact factor: 3.240

10.  Stroke, Research and Science in the Time of COVID.

Authors:  Patrick D Lyden
Journal:  Stroke       Date:  2020-07-31       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.